Company Profile
DynaCord LLC manufactures exosomes derived from human umbilical cord mesenchymal stem cells (UC-MSCs) sourced from Wharton's Jelly. The company partners with local hospitals to obtain umbilical cord and placenta tissue under IRB approval. All manufacturing occurs in a cGMP laboratory with an ISO 5 cleanroom in Baton Rouge, Louisiana.
DynaCord operates two product lines. The first covers cosmetic and topical wound healing products, which face less regulatory burden and faster FDA approval pathways. The company holds a US patent for room temperature stability of topical exosomes and is pursuing an IND for wound healing. The second product line covers injectable exosomes, which require more stringent FDA oversight and pre-clinical testing. DynaCord is the first company with a registered FDA Master File as a Biologic Drug for research use.
Researchers and clinicians obtain DynaCord exosomes for clinical studies. The company is working with orthopedic surgeons on an IND application for spine surgeries and bone regeneration.
Product Lines
Injection
Sterile vial
Infusion
Sterile vial
Eye Drops
Case of 10x 5mL droppers
Topical
Cream, lotion, syrup
Wound Care
Hydro Gel spray, bandage
Dermatology
Aesthetic spray
Ear Drops
Calibrated dropper
Clinical Inhalation
Nebulizer dropper
Home Inhalation
Pressurized inhaler
Regulatory Milestones
Partners
LSU School of Medicine
Research and Development
PharmaZu
Pet Pharmaceutical Products
The Physicians Alliance
Accountable Care Organization